Atea Pharmaceuticals Inc (AVIR)

Sales/Maturities of Investments

$68.13M

Quarterly · Period ending: · USD

AVIR logo

AVIR Sales/Maturities of Investments

Latest reported$68.13M
AVIR Quarterly Sales/Maturities of Investments ($0.00 → $68.13M)
High-resolution chart · PNG

AVIR sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atea Pharmaceuticals Inc Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
68,125,000
104,284,000
90,383,000
56,083,000
116,020,000
208,246,000
55,105,000
106,229,000
131,950,000
223,998,000
75,001,000
146,775,000
199,783,000
181,106,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.